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Proteins antigenically related to the human erythrocyte glucose
transporter in normal and Rous sarcoma virus-transformed
chicken embryo fibroblasts
(membrane alterations/malignant transformation)

DONALD W. SALTER*t, STEPHEN A. BALDWIN0, GUSTAV E. LIENHARDt, AND MICHAEL J. WEBER*
*Department of Microbiology, University of Illinois, Urbana, Illinois 61801; and tDepartment of Biochemistry, Dartmouth Medical School, Hanover,
New Hampshire 03755

Communicated by C. Ladd Prosser, November 30, 1981

ABSTRACT Antibody raised against the purified human
erythrocyte glucose transporter specifically precipitated four proteins from normal and Rous sarcoma virus-transformed chicken
embryo -cells: a major protein of Mr 41,000 and minor proteins of
Mr 68,000, 73,000, and 82,000. The Mr 41,000 and 82,0 proteins
were found only in a membrane fraction, not in the soluble fraction, and displayed a heterogeneous mobility on NaDodSOd
polyacrylamide gel electrophoresis, suggesting glycosylation. The
Mr 41,000 and 82,000 proteins were increased in amount after
malignant transformation in direct proportion to the increase in
hexose transport rate, and the increase was dependent on the
expression of the src gene product, as revealed with a temperature-conditional src mutant. We suggest that the Mr 41,000 and
82,000 proteins are the glucose transporter of chicken embryo fibroblasts, or a component of the glucose transporter. These experiments provide .direct evidence that malignant transformation
increases the rate of glucose transport by increasing the number
of transporters in the membrane.

D-glucose, and this "glucose-specific" cytochalasin B binding
was increased in transformed cells which displayed a high hexose transport rate. Because it had been shown that the purified

glucose transporter from human erythrocytes bound cytochalasin B (11, 12), this result provided strong, but still indirect,
evidence for the suggestion that transformed cells contain increased numbers of glucose transporters in their membranes.
In addition to their cytochalasin binding properties the
chicken embryo cell glucose transporter and the human erythrocyte glucose transporter share the following-features: both are
facilitated diffusion systems (2, 13) and, to the extent that substrate specificity has been determined, both have similar specificities (2, 14). These similarities suggested to us the possibility
that the two proteins might have some antigenic similarities.
Since Baldwin and Lienhard (14) recently characterized an antiserum prepared against the purified human erythrocyte transporter, it became possible to determine whether immunologically crossreactive proteins could be found in chicken embryo
cell membranes and whether these proteins increased in
amount during malignant transformation. While this work was
in progress, Sogin and Hinkle (15) reported immunological
crossreactivity between the human erythrocyte transporter and
proteins of cultured mammalian cells. We have found proteins
in chicken embryo cells that appear to be antigenically related
to the human erythrocyte glucose transporter. Two of these
proteins are probably glycosylated, are found in a crude membrane fraction, and increase in approximately direct proportion
to the. glucose transport rate upon transformation.

Malignant transformation of chicken embryo cells by Rous sarcoma virus (RSV) causes a striking increase in the rate at which
these cells transport glucose across the cell membrane (1-4).
Despite much research, little is known about the molecular
basis for this alteration. It is clear that the activity of the viral
transforming protein pp6Osrc is essential for the increase in glucose transport because viral mutants coding for a temperaturesensitive pp6Osrc are temperature-sensitive in their ability to
increase the transport rate (5, 6). Inhibitor data suggest that the
increased transport rate requires new protein synthesis but not
new RNA synthesis (6, 7). Induction of the increased, transport
requires a functional nucleus (8). The mechanism by which
pp60src causes this increase in transport rate is completely
unknown.
In theory, it seems possible that pp6osrc could act (i) to increase the number ofnormal cellular transporters, (ii) to induce
the synthesis of a new class of transporters, or (iii) to increase
the activity of preexisting transporters. The fact that transformation results in an increase in the maximal velocity for transport but does not detectably change the half-saturation constant
(2, 3) has been -used to argue for-the first hypothesis-namely,
that transformation causes an increase in the number of normal
carriers. However, this argument is a weak one because cases
are known in which allosteric regulation causes an increase in
the maximal velocity without affecting the half-saturation constant for substrate. (9). Recently, Salter and Weber (10) demonstrated that a portion of the binding of cytochalasin B to
chicken embryo cells could be stereospecifically inhibited by

MATERIALS AND METHODS
Virus Strains. The Schmidt-Ruppin strain of RSV subgroup
A (SR-RSV) and its temperature-conditional mutant counterpart, tsNY68, were obtained originally from S. Kawai and H.
Hanafusa (Rockefeller. University) (6).
Sera. The preparation of preimmune serum (about 6 mg of
IgG per ml) and antiserum against the human erythrocyte glucose transporter (about 13 mg of IgG per ml) has been described
(14). Normal rabbit serum was prepared from an unrelated,
unimmunized rabbit.
Other Materials. [35S]Methionine, [32P]phosphate, and
EN3HANCE were obtained from New England Nuclear. Protein A-Sepharose was obtained from Sigma. The human erythrocyte glucose transporter was purified in the presence of the
detergent octaethylene glycol n-dodecyl ether and reconstituted
with additional dioleoylphosphatidylcholine as described (16).
The preparations contained 118. ,g of protein and 3.5 jig of
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phospholipid per ml. All other chemicals were of reagent grade
or higher quality.
Cells and Cell Culture. Fibroblasts were obtained from 11day gs-/chf- chicken embryos (Spafas, Norwich, CT) and cultured as described (2). Secondary cell cultures were infected
with SR-RSV (subgroup A) or tsNY68 and maintained at 40'C
or 420C, respectively; uninfected cells were maintained at 40'C.
Prior to radiolabeling, tertiary cell cultures were plated at 1.8
X 106, 1.4 X 106, and 1.1 x 106 cells per 100-mm dish (Corning)
for SR-RSV, tsNY68, and normal cells, respectively, and incubated at the temperature indicated above. Because of differences in the efficiency of attachment, this provides cell cultures
with similar densities. In addition, the use ofmedium with high
glucose and the protocol of medium changes (see below) were
sufficient to prevent glucose depletion.
Radiolabeling and Preparation of Cell Fractions. For
[3S]methionine labeling, 30 hr after subculture, the medium
was changed to medium containing 4% calf serum, 1% heat-inactivated chicken serum, and only 0.01 mM nonradioactive Lmethionine plus [3S]methionine (150-300 gCi/100-mm dish;
1 Ci = 3.7 x 1010 becquerels). For [32P]phosphate labeling, the
medium was changed to phosphate-free medium containing 4%
calf serum, 1% heat-inactivated chicken serum, and isotope at
500 ,uCi/100-mm dish. One tsNY68-infected culture was then
shifted to the permissive temperature (360C), and the cultures
were then incubated for approximately 24 hr. Particulate and
soluble fractions were prepared from the radiolabeled cells by
the method ofEsko et aL (17). In a typical cell fractionation, 22%
and 27% of the total cell protein was found in the particulate
fraction from transformed and normal cells, respectively. Similar values were obtained with tsNY68-infected cells labeled at
the permissive or nonpermissive temperature.
The trichloroacetic acid-insoluble [3S]methionine-labeled
proteins of the soluble and particulate fractions had approximately the same specific activities, 1 x 105 and 1.2 X 105 cpm/
pug of protein, respectively.
Preparation of Extracts. The particulate fraction was extracted with radioimmunoprecipitation assay lysis buffer (18)
(50 mM Tris HCl, pH 7.5/150 mM NaCl/1% Nonidet P-40/
1% sodium deoxycholate/0. 1% sodium dodecyl sulfate) containing 100 units of Trasylol (FBA Pharmaceuticals) at a protein
concentation of approximately 0.18 ,g/,l. Samples were incubated for 2 hr at 4°C with intermittent mixing and then centrifuged for 15 min in an Eppendorf Microfuge at 12,500 X g;
the pellet was discarded. An extract of purified glucose transporter was similarly prepared. In a typical experiment, 44%,
75%, 74%, and 75% of the [3S]methionine-labeled proteins
were extracted from the particulate fractions of normal cells, SRRSV-infected cells, tsNY68-infected cells at 36°C, and tsNY68infected cells at 420C, respectively. The apparent low value for
normal cells appeared to be due to a larger amount of radiolabeled fibronectin present in the particulate fraction of normal
cells in comparison to the other cells. Polyacrylamide gel electrophoresis revealed that little or no fibronectin was solubilized
under these conditions but that there was no preferential extraction of any other major proteins between the cell types (data
not shown).
Immunoprecipitation. Extracts were incubated with antiserum and the antigen-antibody complexes formed were collected by binding to protein A-Sepharose. In a typical experiment, 125-150 A1l of radiolabeled extract, containing 18-22 ,g
of particulate proteins, was incubated with either 5 or 10 ,ul of
unblocked or blocked antiserum or 10 Al of preimmune serum.
Control experiments demonstrated that antiserum was in ex-

Blocked antiserum was prepared by preincubating 30 Al
of solubilized, purified glucose transporter (1.8 ug of protein

cess.
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and 53 ,g of phospholipid) with the antiserum for 15 min prior
to the addition of labeled extracts. Protein A-Sepharose was
prepared by rehydrating 70 mg in 1 ml of water overnight and
resuspending in 1 ml of 0.05% Nonidet P-40/150 mM NaCl/
5 mM EDTA/50 mM Tris, pH 7.5. An excess (50 gl) of this
slurry was then added to collect the antigen-antibody complexes. Incubation was continued for 1 hr at 40C with intermittent mixing. The protein A-Sepharose-antibody-antigen
complex was centrifuged for 2 min in the Microfuge, and the
pellet was washed seven times with 600 ul of lysis buffer and
once with 10 mM Tris-HCl (pH 7.5) at 40C. Samples were resuspended and then boiled to dissociate the antigen-antibody

complex.
Samples were then electrophoresed (19) and, for [3S]methionine-labeled extracts, fluorographed with EN3HANCE
(20). Under these conditions (with preflashed film), the amount
of radioactivity in a band is approximately proportional to band
intensity. Thus, quantification was performed by scanning autoradiograms with an Ortec model 4310 scanning densitometer.
Electropherograms of [32P]phosphate-labeled extracts were autoradiographed with an intensifying screen (Dupont Lightning
Plus) and exposure at -700C for 5 days.
RESULTS
Crossreactive Proteins in Normal and Transformed Cells.
Fig. 1 shows results obtained when the [3S]methionine-labeled
particulate fraction from transformed and normal chicken fibroblasts was extracted with lysis buffer and the extract was immunoprecipitated with antiserum prepared against the purified
glucose transporter from human erythrocytes. In both transformed and normal cells, there were three proteins-Mr
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FIG. 1. Gel electropherogram of immunoprecipitates of particulate fractions. SR, transformed cells; N, normal cells. Lanes: a, immune
serum, 5 sl; b, immune serum, 10 1l; c, immune serum, 10 IL, plus
purified erythrocyte glucose transporter; d, immune serum, 10 IL, plus
bovine serum albumin; e, normal rabbit serum, 10 ILI; f, preimmune
rabbit serum, 10 Al. The large number of nonspecific bands is often
obtained in immunoprecipitates from the particulate fraction. Mr of
standards are shown x 10'.
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41,000, 73,000, and 82,000-that were immunoprecipitated by

the immune serum (lanes a, b, and d) but not by normal rabbit
serum (lane e) or preimmune serum (lane f). In addition, the
immunoprecipitation of these three bands was blocked by purified glucose transporter plus phospholipid (lane c) but not by
an equivalent amount of bovine serum albumin and phospholipid (lane d). Two of the proteins (Mr 41,000 and 82,000) ran
as broad bands in the gels; this behavior indicates heterogeneity, which in other cases has been found to be due to heterogeneous glycosylation (21, 22). The Mr 73,000 protein electrophoresed as a sharper band. Visual inspection of the
chromatogram revealed that the Mr 41,000 and 82,000 bands
were in much higher amount in transformed cells than in normal
cells (compare lanes a, b, and d within each cell type).
Cells Infected with a Temperature-Conditional src Mutant.
Infection of chicken embryo cells by RSV results not only in
malignant transformation but also in virus production. It is thus
conceivable that the data shown in Fig. 1, which indicate a virusinduced increase in the production of proteins antigenically related to the human erythrocyte glucose transporter, are the
consequence of virus replication rather than transformation. To
distinguish between these possibilities, we made use of tsNY68,
a mutant coding for a temperature-sensitive pp6src. Cells infected with tsNY68 produce high titers of infectious virus at both
360C and at 420C but display the transformed phenotype only
at 36°C (the permissive temperature) (6).
Fig. 2 demonstrates that the increased levels of crossreactive
proteins depend on the activity of pp6(Yrc. As in Fig. 1, proteins
Of Mr 41,000, 73,000, and 82,000 were immunoprecipitated by
immune serum (lanes a, b, and d) but not by normal rabbit
serum (lane e) or preimmune serum (lane f). Immunoprecipitation of these three bands was blocked when purified glucose
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FIG. 2. Gel electropherogram of immunoprecipitates of particulate fractions from cells infected with the temperature-conditional
mutant tsNY68 and held at either the permissive (36°C) or nonpermissive (42°C) temperature. Lanes: a, immune serum, 5 ILI; b, immune
serum, 10 Al; c, immune serum, 10 IlI, plus purified erythrocyte transporter; d, immune serum, 10 pl, plus bovine serum albumin; e, normal
rabbit serum, 10 ,ul; f, preimmune serum, 10 ul.

and phospholipid were included in the reaction
mixture (lane c); an equivalent amount of bovine serum albumin
and phospholipid had little effect on the immunoprecipitation
of these three proteins (lane d). Visual inspection reveals increased amounts of the crossreactive proteins in cells grown at
36°C (the permissive temperature) compared to cells grown at
42°C (the restrictive temperature).
Quantitation of Crossreactive Proteins. Table 1 summarizes
the results of the quantitation of the amount of each of these
three bands in the four different cell types. The data have been
normalized to the value found in normal cells. The amounts of
the Mr 41,000 and 82,000 proteins were significantly increased
in cells transformed by the wild-type SR-RSV and in tsNY68infected cells labeled at the permissive temperature; tsNY68infected cells labeled at the nonpermissive temperature had the
amount of these two protein bands characteristic of normal,
uninfected cells. The Mr 73,000 protein band appeared to be
only slightly increased in the transformed cells; the significance
of this difference is not known.
The transformation-specific difference in the levels of the Mr
41,000 and 82,000 proteins was comparable to the differences
in transport rate generally shown by these cell types when the

transporter

cells were cultured under identical conditions. The uptake of
2-deoxyglucose (nmol/mg of protein per 15 min) was: normal
cells, 11; transformed cells, 32; tsNY68-infected cells, 5 and 25
at 42°C and 36°C, respectively.
Crossreactive Proteins in the Soluble Fraction. We also examined the soluble protein fraction for proteins specifically precipitated by the immune serum (Fig. 3). The Mr 41,000, 73,000,
and 82,000 proteins were not specifically immunoprecipitated
from the soluble portion of the lysed cells. However, small
amounts of a protein of Mr -65,000 were precipitated by the
immune serum, blocked by purified glucose transporter, and
not precipitated with either preimmune serum or normal rabbit
serumn. It appeared that the amount of this protein was not
greatly increased in transformed cells and it was present in
much lesser amount than the three protein bands associated
with the particulate fraction.
It is noteworthy that the preimmune serum precipitated several chicken proteins not precipitated by normal rabbit serum
(serum from an unrelated, unimmunized rabbit) (compare lanes
e and f in Figs. 1 and 2). In particular, a protein of Mr 68,000
was specifically precipitated by the preimmune serum. Immune serum from the same rabbit did not precipitate this protein as strongly as did the preimmune serum at the same or
higher IgG concentration (lanes a and b, Figs. 1 and 2). This
protein band was not blocked with erythrocyte membrane extracts (data not shown) and thus appears to be antigenically unrelated to the glucose transporter. The amount of this protein
did not change with transformation. A protein with a similar Mr
was precipitated from the soluble protein fraction by preimmune serum (Fig. 3). These surprising data may be a consequence of serendipitous crossreaction between certain chicken
cell proteins and the natural antibodies of the rabbit used for
Table 1. Relative amounts of proteins immunoprecipitated by
anti-erythrocyte glucose transporter
Ratio:
Protein
tsNY6&ifected cells
transformed/
band,
360C
420C
normal
Mr
2.7 ± 1.0
0.8 ± 0.1
3.7 ± 1.0
41,000
1.4 ± 0.7
0.8 ± 0.3
1.5 ± 0.7
73,000
3.8 ± 1.5
0.9 ± 0.2
5.6 ± 2.5
82,000
Results are shown as mean ± SD of five independent determinations
on the same extract.
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FIG. 3.

Gel

electropherogram of immunoprecipitates of soluble

fractions from normal and transformed cells. SR, wild-type transformed cells; N, normal cells; tsNY68, infected cells at either permissive

(36QC

or

restrictive (4200) temperature. Lanes: a, immune serum,

10,1.d b, immune serum plus purified erythrocyte transporter; c, preimmune

serum;

d, normal rabbit

immunization. We

serum.

recently prepared another antiserum against

different preparation of the human erythrocyte transporter.
This antiserum also precipitated proteins Of Mr "41,000 and
a

;:=82,000 but the preimmune serum from this rabbit did
precipitate the Mr 68,000 protein.
Crossreactive Proteins Are Not

pp6O'r

is

a

protein kinase (23, 24),

Phosphorylated.

we

wished

to

not

Because

investigate the

possible phosphorylation of the three particulate proteins specifically precipitated by antiserum against the human erythrocyte transporter. fP-Labeledparticulate fractions from normal
and transformed cells were extracted with lysis buffer and precipitated with immune serum. No additional phosphorylated

proteins were immunoprecipitated with immune

serum

when

to preimmune serum under conditions such that the
phosphorylated
pp6t00cprotein could easily be detected (25)
compared

(data not shown).
DISCUSSION

We have used

antisera raised against the purified human eryth-

rocyte transporter to detect immunologically crossreactive pro-

and transformed chicken
experiments,
human

teins in normal

embryo fibroblasts.

When we began these
we were concerned that,
even though the
and the chicken transporter were func-

tionally similar, the evolutionary distance between the chicken
and the human
would not detect immugreat that
was

so

we

nological crossreaction. Our

results

presented

the

opposite

problem: not one but four immunologically crossreactive bands.
Because
41,000

one

protein

has

an

apparent Mr double that of the Mr

protein and because both are coregulated,

found

in

crude membranes, and appear to be glycosylated, we suspect
that the Mr 82,000 protein is a dimer of the Mr 41,000 protein.
About 20% of the protein in preparations of
erythrocyte

purified

glucose

transporter

monomer

[which

(1 1, 22)] often

runs

NaDodSO4/polyacrylamide
published data).

The Mr

has

a

Mr
in

of
the

about

45,000

for the

dimer region

upon

gel electrophoresis (ref. 11;

65,000 protein found

in

the

un-

soluble

fraction of the cell, and the Mr 73,000 protein found with the

membrane fraction

could be

ments of, or unrelated
The

fact

that the

to

amount

precursors

to,

the Mr 41,000 and

of these proteins

proteolytic frag82,000 proteins.

appears

not to

vary
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greatly with transformation argues (albeit, weakly) against the
first two possibilities.
We believe that the MA41,000 and 82,000 protein bands represent the chicken fibroblast glucose transporter or a component ofthe transporter, for the following reasons. (a) These proteins could be precipitated by antisera raised against the human
erythrocyte transporter but not by preimmune or normal sera.
(b) The immunoprecipitation was blocked by purified erythrocyte transporter or by human erythrocyte ghosts; the precipitation was not blocked by bovine erythrocyte ghosts, which do
not possess a cytochalasin-sensitive glucose transport system
(unpublished data). (c) The proteins were found in the membrane fraction of the cells and appeared to be glycosylated. (d)
The amount ofMr 41,000 and 82,000 proteins varied upon transformation in direct proportion to the hexose transport rate of
the cells. (e) The amount of these proteins is comparable to the
amount of glucose-specific cytochalasin B binding displayed by
these cells (see below).
The following calculation indicates that the Mr 41,000 and
82,000 proteins are present in transformed cell membranes in
amounts consistent with their being the glucose transporter.
We previously found (10) that, when cytochalasin B was incubated with the particulate fraction from transformed cells at a
concentration near its apparent dissociation constant, 31.6 pmol
of cytochalasin B was bound per mg of protein to a glucose-inhibitable site. This value converts to approximately 60 pmol of
"glucose-specific" cytochalasin B sites per mg of protein at saturation. In the experiments reported here, we obtained approximately 1800 cpm in the Mr 41,000 plus Mr 82,000 bands
from the particulate fraction of transformed cells. The specific
activity of the total cellular proteins was 81,500 cpm/4g of protein in these experiments, which corresponds to 0.02 Ag of protein in the putative transporters. Because 18.5 ,ug of protein was
used in the immunoprecipitation, there were approximately 1.1
,tg of the Mr 41,000 and 82,000 proteins per mg of total protein
in the particulate fraction. Taking 41,000 as the monomer Mr
and assuming a methionine content in the transporter equivalent to that found in the total cell protein, we calculate that there
were 27 pmol of transporter per mg ofprotein in the particulate
fraction. Considering the assumptions involved in these calculations, and the possibilities for experimental error, we think
that this value is remarkably close to the value, 60 pmol/mg,
obtained from the cytochalasin B measurements.
Although we believe that our antisera recognize the glucose
transporter of chicken embryo cells, we have been unsuccessful
in attempts to immunoprecipitate D-glucose-inhibitable cytochalasin B binding activity from an octyl glucoside extract of
transformed cells. We suspect that this is due to inefficient precipitation of the crossreactive proteins from the detergent extract. Nonetheless, these negative results point out both the
difficulty and the importance of determining unambiguously
the functional identity of the crossreactive proteins.
The transformation-related increase in the Mr 41,000 and
82,000 proteins is dependent on the activity of pp6Osrc because
cells infected with a temperature-conditional mutant of RSV
displayed the increase only at the permissive temperature. Because pp6OrC has been shown to be a protein kinase, it was of
interest to determine whether the putative transporters were
phosphorylated. We were unable to detect phosphorylation of
any of the proteins specifically precipitated by our antiserum,
under conditions in which we can readily detect phosphorylation of pp60rC itself (25). Because the transporter and pp6(Y"'
are present in cells in similar amounts (see above and ref. 26)
we think that this negative result is significant. Thus, it seems
unlikely that the glucose transporter is a primary target of
pp60swrc.
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Our data strongly suggest that the transformation-related increase in glucose transport rate is due to an increased number
of normal cellular transporters. Because the Mr of the putative
transporter is the same in normal and transformed cells and
because our previous studies have not revealed changes in
transport kinetics, specificity, or sensitivity to inhibitors (2, 10),
neither a new transport system (27) nor allosteric effects are
likely to play major roles in increasing the glucose transport rate
in transformed cells.
We thank Barbara Larrain and Margaret Bruesch for excellent technical assistance. This work was supported by U. S. Public Health Service
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